Cargando…
368. Performance Characteristics of Sequencing Assays for Identification of the SARS-CoV-2 Viral Genome
BACKGROUND: As the SARS-CoV-2 (SCV-2) virus evolves, diagnostics and vaccines against novel strains rely on viral genome sequencing. Researchers have gravitated towards the cost-effective and highly sensitive amplicon-based (e.g. ARTIC) and hybrid capture sequencing (e.g. SARS-CoV-2 NGS Assay) to se...
Autores principales: | Antaki, Danny, Couto-Rodriguez, Mara, Liu, Tong, Butcher, Kristin, Toro, Esteban, Höglund, Bryan, Jirau Serrano, Xavier O, Barrows, Joseph, Connor, Bradley A, Mason, Christopher, O’Hara, Niamh B, Nagy-Szakal, Dorottya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690673/ http://dx.doi.org/10.1093/ofid/ofab466.569 |
Ejemplares similares
-
355. A Novel Likelihood-Based Model to Estimate SARS-CoV-2 Viral Titer from Next-Generation Sequencing Data
por: Wells, Heather L, et al.
Publicado: (2021) -
Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case
por: Connor, Bradley A, et al.
Publicado: (2021) -
423. SARS-CoV-2 NGS Assay Powered by Biotia COVID-DX Software
por: Nagy-Szakal, Dorottya, et al.
Publicado: (2020) -
Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights
por: Nagy-Szakal, Dorottya, et al.
Publicado: (2021) -
149. Extraction-free RT-PCR to Detect SARS-CoV-2 Variants of Concern
por: Harry, Brian L, et al.
Publicado: (2021)